Trial
NCT02227576
Prevention of Thrombocytopenia in Glioblastoma Patients
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
University Hospital, Lille
Collaborators
—
Condition
Thrombocytopenia
Intervention
Romiplostim
Why stopped
Study halted for efficacy following the results of the interim analysis provided for in the protocol on 20 patients.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-04-25